Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension

Hepatology. 1990 Jun;11(6):1066-78. doi: 10.1002/hep.1840110625.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Blood Circulation
  • Calcium Channel Blockers / therapeutic use
  • Fibrosis / physiopathology
  • Humans
  • Hypertension, Portal / drug therapy
  • Hypertension, Portal / etiology
  • Hypertension, Portal / physiopathology*
  • Liver / physiopathology*
  • Methods
  • Models, Cardiovascular
  • Nitrates / therapeutic use
  • Portal System / physiopathology
  • Prostaglandin Antagonists / therapeutic use
  • Serotonin Antagonists / therapeutic use
  • Sympathetic Nervous System / physiopathology
  • Sympathomimetics / therapeutic use

Substances

  • Calcium Channel Blockers
  • Nitrates
  • Prostaglandin Antagonists
  • Serotonin Antagonists
  • Sympathomimetics